Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

FLT3 inhibition as therapy in acute myeloid leukemia: a record of trials and tribulations.

FLT3 inhibition as therapy in acute myeloid leukemia: a record of trials and tribulations. Oncologist. 2011; 16(8):1162-74.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.